The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human, phase I study of AK109, an anti-VEGFR2 antibody, in patients (pts) with advanced or metastatic solid tumors.
 
Nong Xu
No Relationships to Disclose
 
Yulong Zheng
No Relationships to Disclose
 
Haijun Zhong
No Relationships to Disclose
 
Fuyou Zhao
No Relationships to Disclose
 
Huan Zhou
No Relationships to Disclose
 
Chenyu Mao
No Relationships to Disclose
 
Wangxia Lv
No Relationships to Disclose
 
Meiqin Yuan
No Relationships to Disclose
 
Jiong Qian
No Relationships to Disclose
 
Haiping Jiang
No Relationships to Disclose
 
Zishu Wang
No Relationships to Disclose
 
Cheng Xiao
No Relationships to Disclose
 
Ting Liu
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Baiyong Li
No Relationships to Disclose
 
Yu Xia
No Relationships to Disclose